© 2000 by Society
© 2000 by the Society forNeuro-Oncology
Localization of gelatinase-A and gelatinase-B mRNA and protein in humangliomas
Departments of Oncology (S.A.R., H.M.), Clinical Neurosciences (S.A.R., H.M., P.A.F.), Medical Biochemistry (R.N.J.), and Pediatrics (P.A.F.), The University of Calgary, Calgary,Alberta, Canada T2N 4N1; Department of Pathology,Foothills Hospital, Calgary, Alberta, Canada, T2N 2T9 (N.B.R.); School of Biological Sciences, University of East Anglia,Norwich, Norfolk, England NR4 7TJ (D.R.E.); and the Department of Medicine, Tom Baker Cancer Centre, Calgary,Alberta, Canada T2N 4N2 (P.A.F.)
1 Address correspondence and reprint requests to Peter Forsyth, Tom Baker CancerCentre, 1331 29th St. N.W., Calgary, Alberta, Canada.
| Abstract |
|---|
Malignant gliomas maintain a poor prognosis and survival rate due to theirmarked local invasive growth and neovascularization. Matrix metalloproteinases(MMPs) have been implicated in glioma invasion and angiogenesis, but it isunknown whether they are produced by the tumor cells or surrounding stroma.Using in situ hybridization and immunohistochemistry, we found expression ofmRNA for both gelatinase-A (MMP2) and gelatinase-B (MMP9) localized to tumorcells and vascular structures in glioma sections. Gelatinase-A proteinexpression was detected most prominently in tumor cells, with very littlesignal seen in vasculature. Gelatinase-B protein expression was prominent invascular structures but was also expressed in tumor cells. Our data show thatthese proteases are produced by glioma cells and vascular structures andsuggest that synthetic MMP inhibitors might be useful in this disease.
Received September 9, 1999; Accepted February 2, 2000
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Baumann, P. Leukel, A. Doerfelt, C. P. Beier, K. Dettmer, P. J. Oefner, M. Kastenberger, M. Kreutz, T. Nickl-Jockschat, U. Bogdahn, et al. Lactate promotes glioma migration by TGF-{beta}2-dependent regulation of matrix metalloproteinase-2 Neuro Oncology, August 1, 2009; 11(4): 368 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Delamarre, S. Taboubi, S. Mathieu, C. Berenguer, V. Rigot, J.-C. Lissitzky, D. Figarella-Branger, L. Ouafik, and J. Luis Expression of Integrin {alpha}6{beta}1 Enhances Tumorigenesis in Glioma Cells Am. J. Pathol., August 1, 2009; 175(2): 844 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Mayes, Y. Hu, Y. Teng, E. Siegel, X. Wu, K. Panda, F. Tan, W.K. A. Yung, and Y.-H. Zhou PAX6 Suppresses the Invasiveness of Glioblastoma Cells and the Expression of the Matrix Metalloproteinase-2 Gene. Cancer Res., October 15, 2006; 66(20): 9809 - 9817. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Brat, A. A. Castellano-Sanchez, S. B. Hunter, M. Pecot, C. Cohen, E. H. Hammond, S. N. Devi, B. Kaur, and E. G. Van Meir Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population Cancer Res., February 1, 2004; 64(3): 920 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Choe, J. K. Park, L. Jouben-Steele, T. J. Kremen, L. M. Liau, H. V. Vinters, T. F. Cloughesy, and P. S. Mischel Active Matrix Metalloproteinase 9 Expression Is Associated with Primary Glioblastoma Subtype Clin. Cancer Res., September 1, 2002; 8(9): 2894 - 2901. [Abstract] [Full Text] [PDF] |
||||



